Regulus Therapeutics Inc. (RGLS) Rose 6.03% or 0.07 To Price $1.23 On Tuesday

Regulus Therapeutics Inc. (RGLS) rose 6.03% or 0.07 to $1.23. It is nearly 122850 shares traded, which is 20.31% compare to the average total volume 604903. The market cap of RGLS is $127.86 million. The year to date change is 2.65%. The 52 week price range is from $0.79 to $1.95. Price of RGLS have changed 2.65% during last week. It have changed -5.69% over last month, 26.79% over last 3 months, 23.55% over last 6 months and -5.31% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for RGLS is 1.11. It is -9.76% below current price. The 200-day Moving Averages for RGLS is 1.15. It is -6.50% below current price. The 52-week High is 1.95. It is 58.54% from the current price. The 52-week Low is 0.79. It is -35.77% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of RGLS is 2.81 on 2018-01-31. Short % to float is 1.94%. There are some statistics of RGLS. It is has market cap $127.86 million. The share outstanding is 103.96 million. The average volume is 604903. The revenue is 72000. The percent of top 15 Institution holding is 69.10%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of RGLS is -127.78%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of RGLS is -74.82%.


Share this post